INVO Bioscience, Inc. (INVO Bioscience), a medical device company focused on treatment options for patients diagnosed with infertility, has signed three distribution contracts in South and Latin America with The Daxley Group (Daxley). The contract provides Daxley to distribute for INVO Bioscience in Columbia, Venezuela, Ecuador, Panama, Mexico, Brazil, Chili, Argentina and Uruguay.

“These agreements will allow INVO to begin the process of treating over 9 million estimated infertile couples in South and Latin America. INVO Bioscience’s goal is to develop this untapped market and treat 5% of this population over the next 5 years,” said INVO Bioscience chief executive officer Kathleen Karloff.